Table 2.
2003–2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | P value | |
---|---|---|---|---|---|---|---|---|
Total ablations | 43 | 79 | 176 | 233 | 267 | 326 | 380 | NA |
Cough which resolved | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (0.4%) | 2 (0.7%) | 0 (0.0%) | 1 (0.3%) | =0.22 |
Groin complications (major + minor) | 0 (0.0%) | 1 (1.3%) | 4 (2.3%) | 1 (0.4%) | 6 (2.2%) | 1 (0.3%) | 1 (0.3%) | =0.11 |
Esophageal irritation | 0 (0.0%) | 0 (0.0%) | 1 (0.6%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | =0.22 |
PV stenosis >50% no intervention | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (0.4%) | 0 (0.0%) | 0 (0.0%) | =0.97 |
Pacer lead dislodgment | 0 (0.0%) | 0 (0.0%) | 1 (0.6%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | =0.22 |
Urethral trauma | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (1.3%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | =0.52 |
Severe urinary infection | 0 (0.0%) | 1 (1.3%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | =0.07 |
Pneumonia | 1 (2.3%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (0.3%) | 0 (0.0%) | =0.19 |
Eye keratopathy, transient | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (0.3%) | =0.25 |
Tongue hematoma (major + minor) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 2 (0.5%) | =0.10 |
Elective, non-tamponade pericaridocentesis | 0 (0.0%) | 1 (1.3%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0.07 |
Pericardial tamponade | 1 (2.3%) | 1 (1.3%) | 1 (0.6%) | 3 (1.3%) | 2 (0.7%) | 1 (0.3%) | 0 (0.0%) | =0.02a |
Stroke/TIA | 2 (4.7%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (0.4%) | 1 (0.3%) | 1 (0.3%) | =0.15 |
Severe protamine reaction | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (0.4%) | 0 (0.0%) | 0 (0.0%) | =0.97 |
Heart block | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (0.4%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | =0.52 |
Total | 4 (9.3%) | 4 (5.1%) | 7 (4.0%) | 7 (3.0%) | 13 (4.9%) | 4 (1.2%) | 6 (1.6%) | =0.001a |
TIA transient ischemic attack, NA not applicable
aStatistically significant